Russia okays second COVID-19 Vaccine EpiVacCorona: Putin
Russian Deputy Prime Minister Tatyana Golikova said that she tested EpiVacCorona vaccine herself and experienced no side effects, said the report.
Moscow: Russian President Vladimir Putin on Wednesday announced that the country has registered the second Covid-19 vaccine, according to media reports.
Russia became the first country to give regulatory approval to a Covid-19 vaccine in August when Sputnik V was officially registered ahead of large-scale clinical trial, drawing criticism from some quarters in the scientific community.
The second Russian vaccine to get regulatory approval has been developed by the Vector State Research Centre of Virology and Biotechnology.
Vector's vaccine, dubbed "EpiVacCorona", relies on chemically synthesized peptide antigens of SARS-CoV-2 proteins, conjugated to a carrier protein and adsorbed on an aluminum-containing adjuvant, according to details posted at ClinicalTrials.gov, a database of privately and publicly funded clinical studies conducted around the world.
Read also: Second human trials of Russian Covid vaccine begin in UAE
Putin said that a third Russian vaccine against Covid-19, developed by the Chumakov Centre, would also be registered in the near future, Sputnik news agency reported.
Russian Deputy Prime Minister Tatyana Golikova said that she tested EpiVacCorona vaccine herself and experienced no side effects, said the report.
"The Vector centre is also initiating post-registration clinical trials in the various regions of Russia that would include 40,000 volunteers," she was quoted as saying.
Read also: Dr Reddys submits revised protocol to DCGI for Sputnik V phase 2,3 trials
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.